Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Scott Hansen
Oregon Health & Science University, Department: None
Should you be removed from our database? Contact us at [email protected]. Read more below.
Vir Biotechnology, Inc. (formerly called TomegaVax, Inc.)
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Please see uploaded pdf
Efficacy of Strain 68-1 RhCMV Vectors Expressing 5' Leader Polypeptides
Thus far, RhCMV vectors have been designed to target the major SIV/HIV gene products (Gag, Rev/Tat/Nef, Pol and Env), and, although, quite effective, we have speculated that better efficacy can be achieved if earlier and more abundant HIV/SIV immunogens can be targeted. Since the recent discovery was made that 5'-leader polypeptides are abundantly expressed early in infected cells and are potent T cell immunogens, inclusion of these polypeptides into the CMV vector platform may allow for earlier intercept of HIV/SIV infection and improved vaccine efficacy.
Filed on December 22, 2016.
Tell us what you know about Scott Hansen's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Scott Hansen filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Scott Hansen | Oregon Health & Science University | Conflict of Interest | Vir Biotechnology, Inc. | $40,000 - $59,999 |
| Scott Hansen | Oregon Health & Science University | Conflict of Interest | Vir Biotechnology, Inc. | $0 - $4,999 |
| Scott Hansen | Oregon Health & Science University | Conflict of Interest | TomegaVax, Inc. | $0 - $4,999 |
| Scott Hansen | Oregon Health & Science University | Conflict of Interest | TomegaVax, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.